treatment-resistant depression
Articles tagged treatment-resistant depression from Bright Horizons Psychiatry.
-
TMS vs. Spravato: Which Treatment Is Right for You?
TMS and Spravato are both FDA-approved for treatment-resistant depression — but they work very differently. Compare how they work, speed of relief, side effects, cost, success rates, and…
Read more
-
How Long Does Spravato Take to Work? A Week-by-Week Timeline
Spravato (esketamine) can begin working within 24 hours, but most responders feel meaningful relief over the first four-week induction phase. Here is a realistic, research-backed timeline of what…
Read more
-
Spravato Success Rate: How Well Does Esketamine Work?
Spravato (esketamine) produces a response in roughly 50–70% of patients with treatment-resistant depression and remission in about 30–50% — with even higher figures in some real-world data. Here's…
Read more
-
TMS Success Rate: What the Research Actually Shows
For depression, TMS produces a response in about 50–60% of patients and remission in 30–40% — with higher figures for accelerated protocols. Here's an honest, research-backed look at…
Read more
-
Spravato REMS Program Explained for Maryland Patients
The Spravato REMS program is why the two hour monitoring rule exists. Here is how enrollment works and what Maryland patients should expect.
Read more
-
Spravato vs IV Ketamine vs IM Ketamine Compared
Spravato, IV ketamine, and IM ketamine are related but not interchangeable. Here is how they compare on evidence, cost, insurance, and monitoring.
Read more
-
How to Know if You Have Treatment-Resistant Depression
Learn how to identify treatment-resistant depression and explore advanced options when standard treatments fail to provide relief.
Read more
-
Treatment-Resistant Depression vs. Major Depression
Explore the crucial differences between Major Depression and Treatment-Resistant Depression, including symptoms, diagnoses, and advanced treatment options.
Read more
-
Spravato (Esketamine) for Treatment-Resistant Depression
Spravato is an FDA-approved esketamine nasal spray for treatment-resistant depression. Here is how it works, who qualifies, and what treatment involves.
Read more